Alexander Horke, Igor Tudorache, Günther Laufer, Martin Andreas, Jose Luis Pomar, Daniel Pereda, Eduard Quintana, Marta Sitges, Bart Meyns, Filip Rega, Mark Hazekamp, Robert Cesnjevar, Martin Oliver Schmiady, John Pepper, Ulrich Rosendahl, Artur Lichtenberg, Dmytro Stadnik, Ramadan Jashari, Dietmar Boethig, Dmitry Bobylev, Murat Avsar, Arjang Ruhparwar, Axel Haverich, Serghei Cebotari, Samir Sarikouch
BACKGROUND: Decellularized aortic homografts (DAH) were introduced as a new option for aortic valve replacement (AVR) for young patients. METHODS: A prospective, EU-funded, single-arm, multicentre study in 8 centers evaluating non-cryopreserved DAH for AVR. RESULTS: 144 patients (99 male) were prospectively enrolled in the ARISE Trial between 10/2015 and 10/2018 with a median age of 30.4 yrs, (IQR 15.9-55.1). 45% had undergone previous cardiac operations, with 19% having two or more previous procedures...
March 26, 2024: European Journal of Cardio-thoracic Surgery